IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
about
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells.An IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma.IL-27 Facilitates Skin Wound Healing through Induction of Epidermal Proliferation and Host Defense.Dual Roles of IL-27 in Cancer Biology and Immunotherapy.Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner.PD-L1 interacts with CD80 to regulate graft-versus-leukemia activity of donor CD8+ T cells.IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells.Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma.Significantly mutated genes and regulatory pathways in SCLC-a meta-analysis.Cross-talk between TNF-α and IFN-γ signaling in induction of B7-H1 expression in hepatocellular carcinoma cells.The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy.Immune Cell Metabolism in Tumor Microenvironment.PD-L1 serves as a double agent in separating GVL from GVHD.Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion.Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes.
P2860
Q33798745-8E6B5726-086B-4D6B-80FE-97E3D02EAF7FQ37687254-63B04184-7AE2-4918-83A5-4282FA30C948Q38749945-AE075AA0-AD97-40EA-8E5C-F614636E473BQ38993070-15E26635-C842-4BCD-9916-7DFFF9A9437BQ39158943-438B39F3-F4FB-41C1-8C00-D41450CE9FDEQ39727068-9A2A1CB3-AE07-4D21-A489-8457BE0421D8Q42256164-C8D552E0-40BD-4BCD-B5EC-FE6E3E4C14FBQ42375251-17B65E00-DEE1-460A-8762-21D4E86F5ABFQ42630498-AE60DE57-DA55-43A9-AC2F-6C32FA391718Q47660753-936B2985-15F6-4347-AAEC-D3DB93C78D2BQ48091555-528B66ED-4E72-4C86-B493-5A14E7519B72Q49194479-ED0BD66E-F818-4D37-AEDE-31BBEB53FE61Q50217783-63EDABA4-1CEC-4AEE-AE22-DB326E601D4DQ51054718-8B0F2371-CD10-41AF-80B3-D4B8693D17E5Q55015760-C988CB05-F711-46FD-9A58-EB753DEA72EAQ55365932-0CAA5D77-F47D-4A53-B29C-0E779A1739C9
P2860
IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
@ast
IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
@en
type
label
IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
@ast
IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
@en
prefLabel
IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
@ast
IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
@en
P2860
P50
P356
P1433
P1476
IL-27 induces the expression of IDO and PD-L1 in human cancer cells.
@en
P2093
Gaia Barisione
P2860
P304
43267-43280
P356
10.18632/ONCOTARGET.6530
P407
P50
P577
2015-12-09T00:00:00Z